Apheresis as novel treatment for refractory angina with raised lipoprotein(a): a randomized controlled cross-over trial

AIMS: To determine the clinical impact of lipoprotein apheresis in patients with refractory angina and raised lipoprotein(a) > 500 mg/L on the primary end point of quantitative myocardial perfusion, as well as secondary end points including atheroma burden, exercise capacity, symptoms, and qualit...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Eur Heart J
Egile Nagusiak: Khan, Tina Z., Hsu, Li-Yueh, Arai, Andrew E., Rhodes, Samantha, Pottle, Alison, Wage, Ricardo, Banya, Winston, Gatehouse, Peter D., Giri, Shivraman, Collins, Peter, Pennell, Dudley J., Barbir, Mahmoud
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2017
Gaiak:
Clinical Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6075617/
https://ncbi.nlm.nih.gov/pubmed/28453721
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehx178
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak